- Home
- XCUR vs FSEA Comparison
XCUR vs FSEA Comparison
Compare XCUR & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- FSEA
- Stock Information
- Founded
- XCUR 2011
- FSEA 1890
- Country
- XCUR United States
- FSEA United States
- Employees
- XCUR N/A
- FSEA N/A
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- FSEA Savings Institutions
- Sector
- XCUR Health Care
- FSEA Finance
- Exchange
- XCUR Nasdaq
- FSEA Nasdaq
- Market Cap
- XCUR 59.0M
- FSEA 53.3M
- IPO Year
- XCUR N/A
- FSEA N/A
- Fundamental
- Price
- XCUR $7.86
- FSEA $11.31
- Analyst Decision
- XCUR
- FSEA
- Analyst Count
- XCUR 0
- FSEA 0
- Target Price
- XCUR N/A
- FSEA N/A
- AVG Volume (30 Days)
- XCUR 5.7K
- FSEA 6.0K
- Earning Date
- XCUR 08-12-2025
- FSEA 08-08-2025
- Dividend Yield
- XCUR N/A
- FSEA N/A
- EPS Growth
- XCUR N/A
- FSEA N/A
- EPS
- XCUR N/A
- FSEA 0.00
- Revenue
- XCUR $500,000.00
- FSEA $16,196,000.00
- Revenue This Year
- XCUR N/A
- FSEA N/A
- Revenue Next Year
- XCUR N/A
- FSEA N/A
- P/E Ratio
- XCUR N/A
- FSEA $1,381.37
- Revenue Growth
- XCUR N/A
- FSEA 97.61
- 52 Week Low
- XCUR $1.44
- FSEA $8.60
- 52 Week High
- XCUR $36.00
- FSEA $11.80
- Technical
- Relative Strength Index (RSI)
- XCUR 31.28
- FSEA 51.70
- Support Level
- XCUR $7.53
- FSEA $11.00
- Resistance Level
- XCUR $8.96
- FSEA $11.33
- Average True Range (ATR)
- XCUR 0.69
- FSEA 0.17
- MACD
- XCUR -0.20
- FSEA -0.01
- Stochastic Oscillator
- XCUR 6.42
- FSEA 60.00
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.